Vikram Thermo (India) Ltd
Incorporated in 1985, Vikram Thermo
Ltd manufactures and sells basic pharma
co-polymers[1]
- Market Cap ₹ 453 Cr.
- Current Price ₹ 144
- High / Low ₹ 173 / 73.0
- Stock P/E 18.6
- Book Value ₹ 32.6
- Dividend Yield 0.35 %
- ROCE 24.6 %
- ROE 20.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 49.0% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
35 | 37 | 42 | 37 | 38 | 45 | 49 | 58 | 56 | 74 | 93 | 112 | 125 | |
26 | 28 | 33 | 32 | 31 | 37 | 44 | 49 | 44 | 55 | 78 | 85 | 89 | |
Operating Profit | 9 | 9 | 9 | 5 | 8 | 8 | 5 | 9 | 12 | 18 | 15 | 26 | 37 |
OPM % | 26% | 25% | 22% | 15% | 20% | 19% | 10% | 15% | 21% | 25% | 16% | 23% | 29% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
Profit before tax | 9 | 8 | 8 | 5 | 6 | 7 | 3 | 6 | 9 | 16 | 12 | 23 | 33 |
Tax % | 33% | 33% | 33% | 34% | 34% | 35% | 25% | 28% | 23% | 25% | 26% | 27% | |
6 | 6 | 6 | 3 | 4 | 5 | 2 | 4 | 7 | 12 | 9 | 17 | 24 | |
EPS in Rs | 2.07 | 2.01 | 2.05 | 1.12 | 1.52 | 1.69 | 0.84 | 1.59 | 2.31 | 3.84 | 2.77 | 5.39 | 7.77 |
Dividend Payout % | 14% | 15% | 15% | 13% | 20% | 20% | 12% | 19% | 13% | 8% | 2% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 18% |
3 Years: | 26% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 49% |
3 Years: | 33% |
TTM: | 57% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 56% |
3 Years: | 55% |
1 Year: | 85% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 18% |
Last Year: | 21% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 31 | 31 |
Reserves | 11 | 16 | 21 | 23 | 27 | 32 | 33 | 37 | 48 | 59 | 67 | 58 | 71 |
1 | 2 | 2 | 4 | 1 | 6 | 12 | 14 | 6 | 10 | 15 | 19 | 11 | |
6 | 7 | 8 | 8 | 8 | 10 | 9 | 9 | 13 | 16 | 16 | 19 | 19 | |
Total Liabilities | 24 | 30 | 36 | 41 | 41 | 53 | 60 | 66 | 73 | 92 | 104 | 127 | 133 |
9 | 9 | 9 | 10 | 17 | 21 | 30 | 34 | 34 | 32 | 53 | 61 | 61 | |
CWIP | 0 | 4 | 7 | 9 | 1 | 7 | 4 | 0 | 6 | 18 | 0 | 0 | 0 |
Investments | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 10 | 11 | 11 | 12 |
15 | 17 | 20 | 22 | 22 | 25 | 26 | 32 | 32 | 32 | 40 | 55 | 60 | |
Total Assets | 24 | 30 | 36 | 41 | 41 | 53 | 60 | 66 | 73 | 92 | 104 | 127 | 133 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6 | 5 | 5 | 2 | 2 | 6 | 3 | 4 | 13 | 15 | 6 | 13 | |
-2 | -4 | -4 | -3 | -1 | -10 | -8 | -2 | -10 | -19 | -7 | -13 | |
-2 | -0 | -1 | 1 | -4 | 4 | 4 | 1 | -4 | 3 | 3 | 1 | |
Net Cash Flow | 2 | 1 | 0 | -0 | -2 | -0 | -0 | 3 | -1 | -1 | 1 | 2 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 92 | 87 | 95 | 131 | 139 | 115 | 139 | 138 | 129 | 99 | 93 | 109 |
Inventory Days | 60 | 68 | 62 | 64 | 64 | 98 | 60 | 53 | 97 | 94 | 74 | 64 |
Days Payable | 73 | 97 | 84 | 84 | 81 | 102 | 70 | 52 | 107 | 92 | 62 | 69 |
Cash Conversion Cycle | 79 | 59 | 72 | 111 | 123 | 111 | 128 | 139 | 119 | 101 | 106 | 104 |
Working Capital Days | 78 | 74 | 82 | 120 | 147 | 124 | 120 | 121 | 102 | 81 | 92 | 98 |
ROCE % | 53% | 40% | 33% | 16% | 20% | 19% | 8% | 14% | 17% | 24% | 15% | 25% |
Documents
Announcements
- INTIMATION OF SANCTION OF SCHEME OF ARRANGEMENT INVOLVING DEMERGER BY HON'BLE NATIONAL COMPANY LAW TRIBUNAL, AHMEDABAD BENCH 1d
- Compliance Certificate - Regulation 7(3) Of SEBI (LODR) Regulations, 2015. For Year Ended March 31, 2024 1d
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - The securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records …
- Closure of Trading Window 23 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
VTL is an ISO 9001, DRCOAT and
EXCiPACT International GMP certified integrated, research-based pharmaceutical excipient company. It manufactures, markets, and exports pharmaceutical excipients and chemicals.